Abcam Share Discussion Threads

[stockhound] 13/4/2011 13:58

Nice - breakout coming. About to go turtle green.

[thepsychic] 13/4/2011 12:21

why has this caused a flurry of trades? It is too late to buy in to claim a dividend.

[quickmind] 13/4/2011 12:13

Friday April 15: Abcam (INTERIM DIVIDEND PAYMENT DATE)

[thepsychic] 13/4/2011 12:11

does anyone know why the sudden rush of trades?

[toonces] 12/4/2011 22:37

Would one know what that corporate action pending (on 15/04/2011) is about?

[cambium] 08/4/2011 15:26

Welcome back GI

[greek islander] 08/4/2011 15:18

Back in here today after a short absence.
This stock provided me last time around with one of my most substantial profits.
Have been on the sidelines waiting...............

[greek islander] 08/4/2011 15:18

repeat posting

[megsta] 08/4/2011 12:14

decent support @ £3.64. where next?

[rockafella2] 07/4/2011 12:52

Good interview with Jonathan Milner CEO http://www.stockopedia.co.uk/content/abcam-the-next-giant-of-the-life-sciences-55549/

snippets

"The real key to the business model is understanding that Abcam is in this wonderful position of having access to all the best antibodies in the world which none of our competitors have; once we've got access to all the best antibodies in the world we then put the data sheets on much faster than our competitors; so we have a much more data rich product which is then much more valuable to the scientists than our competitors' products."

"there's so much opportunity, we are so well positioned"

[cambium] 07/4/2011 12:21

Liars you may want to post this in the header as it highlights what ABC do very succinctly

[yespmedc] 22/3/2011 12:15

Upcoming interview with Abcam CEO

[nellie1973] 16/3/2011 14:54

Broker upgrade

[4wingrove] 09/3/2011 18:30

I hold ABC but also hold Standard Life UK smaller companies. His list of other holdings is impressive and he has an enviable past record. Also have holding in Marlborough Special situations which has done very well. Great minds etc.

[cambium] 08/3/2011 23:42

Just don't need to post everyday with this one

[campbed] 08/3/2011 23:38

megSta -- seems an unusual approach to buy Std Life smaller company closed end or open end fund in order to get exposure to Abcam. If you're keen on Abcam why not just buy the individual share? The contrary and more usual approach for PI's is to buy shares in companies that are major holdings of successful investment managers such as Harry Nimmo at Std Life so as to save on their management and admin fees.

A middle road on UK small caps that I follow is to have direct holdings of shares I feel very comfortable with, such as Abcam, as well as holdings in closed end fund of Mr Nimmo and in some open end funds of other good managers such as Giles Hargreave (Marlborough's Special Situations, Micro Cap and UK leading companies). Direct holdings in Abcam also get IHT relief as it's AIM listed if that's a consideration. I don't know why Abcam has so few followers on this board when it is so popular with leading UK small cap investment managers such as the two mentioned above.

[megsta] 08/3/2011 17:50

bought 'Standard Life UK Smaller Companies' in SIPP a while ago due to it holding ABC. I'm glad :)

[campbed] 08/3/2011 12:26

Abcam half year results to 31 Dec released today look good considering points mentioned in my post 288 above.

Good US growth especially on West Coast which justifies small new office there. Japan good - helped of course by strong currency and direct sales. UK still around 10% growth and picking up in Q3. Aborted acquisition cost not treated as exceptional but suggests looking to use cash for other growth streams to justify high P/E rating.

[akhtar8] 08/3/2011 12:00

Abcam comment by GCI

[m.t.glass] 03/3/2011 08:16

"I invest in people who can walk through walls" - the David Cleevely story

(references to Abcam)

[kluk069] 21/2/2011 06:32

Does the indicated 5% dividend actually refer to the current price or is it from the pre share split days?

[nephie] 09/2/2011 11:09

Cambridge, UK: Abcam plc (AIM: ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue, will announce its interim results for the six months ended 31 December 2010 on Tuesday 8 March 2011.

An analyst meeting will be held at 11:00am on Tuesday 8 March at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.

[campbed] 08/2/2011 11:20

Half year results to 31 Dec to be announced on 8 March.



Hopefully will confirm higher growth in US and Japan and at least some growth in UK.

[brownie69] 26/1/2011 08:46

Any analysts reports available on ABC?